EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 6 May 2021. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 4.36 for January-March 2021 as against Tk. 4.08 for January-March 2020; Consolidated EPS was Tk. 13.12 for July 2020-March 2021 as against Tk. 11.85 for July 2019-March 2020. Consolidated NOCFPS was Tk. 9.40 for July 2020-March 2021 as against Tk. 9.64 for July 2019-March 2020. Consolidated NAV per share was Tk. 96.43 as on March 31, 2021 and Tk. 87.28 as on June 30, 2020. Reason for Significant deviation in Consolidated NAV per share, Consolidated EPS (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400539d6
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.